Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sarepta Therapeutics

61.11
+0.25500.42%
Volume:279.66K
Turnover:16.95M
Market Cap:5.93B
PE:26.13
High:61.20
Open:59.98
Low:59.62
Close:60.85
Loading ...
Mar 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 28, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 27, 2025

Major Issues Report

Form 8-K - Current report
Feb 14, 2025

Major Issues Report

Form 8-K - Current report
Jan 13, 2025

Major Issues Report

Form 8-K - Current report
Dec 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 26, 2024

Major Issues Report

Form 8-K - Current report
Nov 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 06, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 16, 2024

Major Issues Report

Form 8-K - Current report
Aug 30, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 07, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 25, 2024

Proposed Sale Of Securities

Form144|Sarepta's Officer Bilal Arif proposes to sell 3898 Shares, with a total value of approximately $638,687
Jun 25, 2024

Proposed Sale Of Securities

Form144|Sarepta Therapeutics' Officer Ryan Brown proposes to sell 38957 Shares, with a total value of approximately $6.38 Million.
Jun 24, 2024

Proposed Sale Of Securities

Form144|Sarepta's Officer Bilal Arif proposes to sell 7859 Shares, with a total value of approximately $1.26 Million.
Jun 07, 2024

Major Issues Report

Form 8-K - Current report
May 01, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 28, 2024

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments